These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9305812)

  • 1. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.
    Granholm AC; Mott JL; Bowenkamp K; Eken S; Henry S; Hoffer BJ; Lapchak PA; Palmer MR; van Horne C; Gerhardt GA
    Exp Brain Res; 1997 Aug; 116(1):29-38. PubMed ID: 9305812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
    Wang Y; Tien LT; Lapchak PA; Hoffer BJ
    Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity.
    Yurek DM; Fletcher-Turner A
    Brain Res; 1999 Oct; 845(1):21-7. PubMed ID: 10529440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE; Hoffman AF; Gerhardt GA; Henry MA; Biddle PT; Hoffer BJ; Granholm AC
    J Comp Neurol; 1995 May; 355(4):479-89. PubMed ID: 7636027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney cografts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery.
    Granholm AC; Henry S; Herbert MA; Eken S; Gerhardt GA; van Horne C
    Cell Transplant; 1998; 7(2):197-212. PubMed ID: 9588601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
    Krobert K; Lopez-Colberg I; Cunningham LA
    Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons.
    Haque NS; LeBlanc CJ; Isacson O
    Cell Transplant; 1997; 6(3):239-48. PubMed ID: 9171157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and electrophysiological correlates of human mesencephalic dopaminergic xenograft function in the rat striatum.
    van Horne CG; Mahalik T; Hoffer B; Bygdeman M; Almqvist P; Stieg P; Seiger A; Olson L; Strömberg I
    Brain Res Bull; 1990 Aug; 25(2):325-34. PubMed ID: 1977499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies.
    Chaturvedi RK; Agrawal AK; Seth K; Shukla S; Chauhan S; Shukla Y; Sinha C; Seth PK
    Int J Dev Neurosci; 2003 Nov; 21(7):391-400. PubMed ID: 14599485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo.
    Johansson M; Friedemann M; Hoffer B; Strömberg I
    Exp Neurol; 1995 Jul; 134(1):25-34. PubMed ID: 7672036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells.
    Pitzer MR; Sortwell CE; Daley BF; McGuire SO; Marchionini D; Fleming M; Collier TJ
    Exp Neurol; 2003 Aug; 182(2):435-45. PubMed ID: 12895454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.